WATSON 3159 (Ursodiol 300 mg)

Pill imprint WATSON 3159 has been identified as Ursodiol 300 mg.

Ursodiol is used in the treatment of biliary cirrhosis; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 3159

Ursodiol 300 mg WATSON 3159 Front
Ursodiol 300 mg WATSON 3159 Back
Ursodiol 300 mg WATSON 3159
Ursodiol 300 mg WATSON 3159
Ursodiol
Imprint:
WATSON
3159
Strength:
300 mg
Color:
White
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Gallstone solubilizing agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3159
Inactive Ingredients:
silicon dioxide colloidal
ferric oxide
gelatin
magnesium stearate
corn starch
ferrosoferric oxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0213 Amerisource Health Services

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)